St Luke's Cancer Institute is a clinical research site located in Boise, Idaho, United States 83712.
Crixeo Clinical Trials Trust Score: 16/100 (FAILING). This profile has not yet been claimed by the site owner.
St Luke's Cancer Institute has participated in 9 clinical trials with 5 currently active.
Therapeutic areas: Multiple Myeloma, PDAC, PDAC - Pancreatic Ductal Adenocarcinoma.
Sponsors: Kite, A Gilead Company, Revolution Medicines, Inc., Genentech, Inc..
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Idaho · View every site in Boise
Trust Score: 16/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
St Luke's Cancer Institute has a Crixeo Trust Score of 16/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
St Luke's Cancer Institute has 9 clinical trials on record, with 5 currently active. Their work covers Multiple Myeloma, PDAC, PDAC - Pancreatic Ductal Adenocarcinoma.
St Luke's Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.